Polymerized α1-antitrypsin is present on lung vascular endothelium. New insights into the biological significance of α1-antitrypsin polymerization

Histopathology

Volumn 45, Issue 6, 2004, Pages 587-592

  Aldonyte, R ^a   Jansson, L ^c   Ljungberg, O ^b   Larsson, S ^a   Janciauskiene, S ^a,d  

^a Department of Medicine ^*  (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c ASTRAZENECA R AND D   (Sweden)

^d Malmo University Hospital   (Sweden)

Author keywords

1 antitrypsin; COPD; Endothelial cells; Polymers

Indexed keywords

ALPHA 1 ANTITRYPSIN; ISOPROTEIN; LEUKOCYTE ELASTASE; MONOCLONAL ANTIBODY; POLYMER;

ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; CADAVER; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; EMPHYSEMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG BLOOD VESSEL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN POLYMERIZATION; TISSUE DISTRIBUTION; VASCULAR ENDOTHELIUM; CHEMISTRY; COMPARATIVE STUDY; LUNG; METABOLISM; PATHOLOGY;

ALPHA 1-ANTITRYPSIN; ENDOTHELIUM, VASCULAR; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG; POLYMERS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 11144344472     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2004.02021.x     Document Type: Article

References (33)

1. Stevens T, Rosenberg R, Aird W et al. NHLBI workshop report: endothelial cell phenotypes in heart, lung, and blood diseases. Am. J. Physiol. Cell Physiol. 2001; 281; C1422-C1433.
2. Chow CK. Cigarette smoking and oxidative damage in the lung. Ann. NY Acad. Sci. 1993; 686; 289-298.
3. Kasahara Y, Tuder RM, Taraseviciene-Stewart L et al. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J. Clin. Invest. 2000; 106; 1311-1319.
4. Hale KA, Niewoehner DE, Cosio MG. Morphologic changes in the muscular pulmonary arteries: relationship to cigarette smoking, airway disease, and emphysema. Am. Rev. Respir. Dis. 1980; 122; 273-278.
5. Peinado VI, Barbera JA, Ramirez J et al. Endothelial dysfunction in pulmonary arteries of patients with mild COPD. Am. J. Physiol. 1998; 274; L908-L913.
6. Squire JM, Chew M, Nneji G et al. Quasi-periodic substructure in the microvessel endothelial glycocalyx: a possible explanation for molecular filtering? J. Struct. Biol. 2001; 136; 239-255.
7. Page C, Rose M, Yacoub M et al. Antigenic heterogeneity of vascular endothelium. Am. J. Pathol. 1992; 141; 673-683.
8. Cines DB, Pollak ES, Buck CA et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 1998; 91; 3527-3561.
9. Minshall RD, Tiruppathi C, Vogel SM et al. Vesicle- formation and trafficking in endothelial cells and regulation of endothelial barrier function. Histochem. Cell. Biol. 2002; 117; 105-112.
10. Fischer HP, Ortiz-Pallardo ME, Ko Y et al. Chronic liver disease in heterozygous alpha 1-antitrypsin deficiency PiZ. J. Hepatol. 2000; 33; 883-892.
11. Forsyth KD, Talbot V, Beckman I. Endothelial serpins - protectors of the vasculature? Clin. Exp. Immunol. 1994; 95; 277-282.
12. Janciauskiene S, Dominaitiene R, Sternby NH et al. Detection of circulating and endothelial cell polymers of Z and wild type alpha 1-antitrypsin by a monoclonal antibody. J. Biol. Chem. 2002; 277; 26540-26546.
13. Yao J, Baecher-Allan CM, Sharon J. Serpins identified as cell growth inhibitors in human plasma. Mol. Cell. Biol. Res. Commun. 2000; 3; 76-81.
14. Travis J, Shieh BH, Potempa J. The functional role of acute phase plasma proteinase inhibitors. Tokai J. Exp. Clin. Med. 1988; 13; 313-320.
15. Wawrzos I, Kitagawa Y, Koloczek H. Immunological discrimination of diverse forms of human alpha 1-proteinase inhibitor. Acta Biochim. Pol. 1996; 43; 481-488.
16. Zhu XJ, Chan SK. The use of monoclonal antibodies to distinguish several chemically modified forms of human alpha 1-proteinase inhibitor. Biochem. J. 1987; 246; 19-23.
17. Wong PS, Travis J. Isolation and properties of oxidized alpha-1-proteinase inhibitor from human rheumatoid synovial fluid. Biochem. Biophys. Res. Commun. 1980; 96; 1449-1454.
18. Janciauskiene S. Conformational properties of serine proteinase inhibitors (serpins) confer multiple pathophysiological roles. Biochi. Biophys. Acta 2001; 1535; 221-235.
19. Elliott PR, Pei XY, Dafforn TR et al. Topography of a 2.0 A structure of alpha1-antitrypsin reveals targets for rational drug design to prevent conformational disease. Protein Sci. 2000; 9; 1274-1281.
20. Kalsheker N, Morgan K. Molecular biology and respiratory disease. 7. The alpha 1 antitrypsin gene and chronic lung disease. Thorax 1990; 45; 759-764.
21. Eriksson S. Alpha 1-antitrypsin deficiency. J. Hepatol. 1999; 30; 34-39.
22. Joos L, Pare PD, Sandford AJ. Genetic risk factors of chronic obstructive pulmonary disease. Swiss Med. Wkly 2002; 132; 27-37.
23. Hill AT, Campbell EJ, Bayley DL et al. Evidence for excessive bronchial inflammation during an acute exacerbation of chronic obstructive pulmonary disease in patients with alpha(1)-antitrypsin deficiency (PiZ). Am. J. Respir. Crit. Care Med. 1999; 160; 1968-1975.
24. Sveger T. Liver disease in alpha1-antitrypsin deficiency detected by screening of 200,000 infants. N. Engl. J. Med. 1976; 294; 1316-1321.
25. Durr R, Caselmann WH. Carcinogenesis of primary liver malignancies. Langenbeck's Arch. Surg. 2000; 385; 154-161.
26. Reid PT, Sallenave JM. Neutrophil-derived elastases and their inhibitors: potential role in the pathogenesis of lung disease. Curr. Opin. Invest. Drugs 2001; 2; 59-67.
27. Mahadeva R, Lomas DA. Genetics and respiratory disease. 2. Alpha 1-antitrypsin deficiency, cirrhosis and emphysema. Thorax 1998; 53; 501-505.
28. Dafforn TR, Mahadeva R, Elliott PR et al. A kinetic mechanism for the polymerization of alpha1-antitrypsin. J. Biol. Chem. 1999; 274; 9548-9555.
29. Wallmark A, Alm R, Eriksson S. Monoclonal antibody specific for the mutant PiZ alpha 1-antitrypsin and its application in an ELISA procedure for identification of PiZ gene carriers. Proc. Natl Acad. Sci. USA 1984; 81; 5690-5693.
30. Tsujii T, Katayama K, Naito I et al. The circulating alpha 1-antitrypsin-elastase complex attacks the elastic lamina of blood vessels. An immunohistochemical study. Histochemistry 1988; 88; 443-451.
31. Janciauskiene S, Toth E, Sahlin S et al. Immunochemical and functional properties of biliary alpha-1-antitrypsin. Scand. J. Clin. Lab. Invest. 1996; 56; 597-608.
32. Parmar JS, Mahadeva R, Reed BJ et al. Polymers of alpha(1)-antitrypsin are chemotactic for human neutrophils: a new paradigm for the pathogenesis of emphysema. Am. J. Respir. Cell. Mol. Biol. 2002; 26; 723-730.
33. Janciauskiene S, Zelvyte I, Jansson L et al. Divergent effects of alpha1-antitrypsin on neutrophil activation, in vitro. Biochem. Biophys. Res. Commun. 2004; 315; 288-296.